Mutual of America Capital Management’s ResMed RMD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$2.92M Sell
15,001
-538
-3% -$112K 0.03% 647
2026
Q1
$3.49M Sell
15,539
-176
-1% -$43.9K 0.04% 531
2025
Q4
$3.79M Sell
15,715
-193
-1% -$49.4K 0.04% 531
2025
Q3
$4.35M Sell
15,908
-939
-6% -$256K 0.05% 493
2025
Q2
$4.35M Sell
16,847
-269
-2% -$64.2K 0.05% 494
2025
Q1
$3.83M Sell
17,116
-508
-3% -$119K 0.04% 539
2024
Q4
$4.03M Sell
17,624
-510
-3% -$123K 0.04% 555
2024
Q3
$4.43M Sell
18,134
-435
-2% -$97.2K 0.05% 525
2024
Q2
$3.55M Sell
18,569
-760
-4% -$154K 0.04% 628
2024
Q1
$3.83M Sell
19,329
-396
-2% -$72.6K 0.04% 612
2023
Q4
$3.39M Sell
19,725
-878
-4% -$135K 0.04% 657
2023
Q3
$3.05M Sell
20,603
-573
-3% -$104K 0.04% 663
2023
Q2
$4.63M Buy
21,176
+112
+0.5% +$25K 0.05% 498
2023
Q1
$4.61M Buy
21,064
+95
+0.5% +$20.6K 0.05% 511
2022
Q4
$4.36M Buy
20,969
+654
+3% +$144K 0.05% 525
2022
Q3
$4.43M Buy
20,315
+327
+2% +$74.4K 0.06% 465
2022
Q2
$4.19M Buy
19,988
+438
+2% +$93.2K 0.05% 523
2022
Q1
$4.74M Buy
19,550
+272
+1% +$65.8K 0.05% 561
2021
Q4
$5.02M Buy
19,278
+155
+0.8% +$40.2K 0.05% 553
2021
Q3
$5.04M Buy
19,123
+111
+0.6% +$30.4K 0.05% 524
2021
Q2
$4.69M Buy
19,012
+227
+1% +$47.7K 0.05% 563
2021
Q1
$3.65M Buy
18,785
+512
+3% +$103K 0.04% 696
2020
Q4
$3.88M Sell
18,273
-659
-3% -$131K 0.04% 592
2020
Q3
$3.25M Sell
18,932
-852
-4% -$157K 0.04% 586
2020
Q2
$3.8M Buy
19,784
+183
+0.9% +$29.9K 0.05% 485
2020
Q1
$2.89M Buy
19,601
+98
+0.5% +$15.6K 0.05% 524
2019
Q4
$3.02M Buy
19,503
+254
+1% +$36.6K 0.04% 722
2019
Q3
$2.6M Buy
19,249
+107
+0.6% +$14K 0.04% 740
2019
Q2
$2.34M Buy
19,142
+117
+0.6% +$13K 0.03% 813
2019
Q1
$1.98M Buy
19,025
+223
+1% +$23K 0.03% 870
2018
Q4
$2.14M Buy
18,802
+364
+2% +$39K 0.04% 771
2018
Q3
$2.13M Buy
18,438
+43
+0.2% +$4.71K 0.03% 878
2018
Q2
$1.91M Buy
18,395
+118
+0.6% +$11.9K 0.03% 908
2018
Q1
$1.8M Buy
18,277
+1,387
+8% +$131K 0.03% 893
2017
Q4
$1.43M Buy
16,890
+591
+4% +$48.8K 0.02% 1002
2017
Q3
$1.25M Sell
16,299
-98,581
-86% -$7.54M 0.02% 1025
2017
Q2
$8.95M Buy
114,880
+1,995
+2% +$143K 0.15% 111
2017
Q1
$8.12M Buy
112,885
+3,958
+4% +$274K 0.14% 126
2016
Q4
$6.76M Buy
108,927
+1,716
+2% +$105K 0.13% 175
2016
Q3
$6.95M Buy
107,211
+2,846
+3% +$189K 0.14% 142
2016
Q2
$6.6M Buy
104,365
+8,702
+9% +$513K 0.14% 141
2016
Q1
$5.53M Buy
95,663
+1,845
+2% +$104K 0.12% 181
2015
Q4
$5.04M Buy
93,818
+275
+0.3% +$15.5K 0.11% 206
2015
Q3
$4.77M Buy
93,543
+2,808
+3% +$151K 0.11% 209
2015
Q2
$5.12M Sell
90,735
-362
-0.4% -$22.8K 0.11% 208
2015
Q1
$6.54M Buy
91,097
+3,029
+3% +$197K 0.14% 141
2014
Q4
$4.94M Buy
88,068
+258
+0.3% +$13.5K 0.11% 213
2014
Q3
$4.33M Buy
87,810
+1,027
+1% +$52.3K 0.1% 237
2014
Q2
$4.39M Sell
86,783
-1,687
-2% -$83.6K 0.1% 239
2014
Q1
$3.95M Buy
88,470
+1,139
+1% +$51.2K 0.1% 296
2013
Q4
$4.11M Buy
87,331
+601
+0.7% +$30.4K 0.1% 271
2013
Q3
$4.58M Buy
86,730
+3,574
+4% +$173K 0.13% 181
2013
Q2
$3.75M Buy
+83,156
New +$3.95M 0.11% 223

Other funds holding RMD

Mutual of America Capital Management's RMD Position: Q2 2026 in Review

Mutual of America Capital Management reduced its ResMed (RMD) stake by 3.5% in Q2 2026, selling an estimated $112K and leaving 15,001 shares worth $2.92M. The position accounts for 0.03% of the portfolio, ranked #647.

Mutual of America Capital Management first reported a position in RMD in Q2 2013 and has held it in 53 quarters since. The position peaked at $8.95M in Q2 2017. 564 funds tracked by Wall St. Rank hold RMD as of Q2 2026.

  • Mutual of America Capital Management held 15,001 shares of ResMed worth $2.92M as of Q2 2026.
  • Mutual of America Capital Management sold 538 ResMed shares in Q2 2026, an estimated $112K.
  • ResMed made up 0.03% of Mutual of America Capital Management's portfolio in Q2 2026, its #647 holding.
  • Mutual of America Capital Management first reported a position in ResMed in Q2 2013 and has held it in 53 quarters since.
  • Mutual of America Capital Management's ResMed position peaked at $8.95M in Q2 2017.
  • 564 funds tracked by Wall St. Rank held ResMed as of Q2 2026.

Based on Mutual of America Capital Management's 13F filing for Q2 2026, filed 11 Aug 2026.